Visceral fat is characterized by higher lipolytic activity than subcutaneous fat; the consequent excessive release of free fatty acids (FFA) could trigger hepatic insulin resistance, modifications of systemic lipid metabolism, and consequent overt dyslipidemia, leading to increased CVD risk [9]. This evidence concerns the gene INS and metabolic syndrome.